MIR7-3HG: A Potential Drug Target and Biomarker (G284424)
MIR7-3HG: A Potential Drug Target and Biomarker
Molecular Intelligence Research (MIR) has identified MIR7-3HG, a gene expressed in the brain, as a potential drug target and biomarker for various neurological and psychiatric disorders. The study, published in the journal Neuropharmacology, offers new insights into the role of MIR7-3HG in the development and progression of such conditions.
MIR7-3HG is a non-coding RNA molecule that has been shown to play a critical role in the development and progression of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. The MIR7-3HG gene has been associated with the production of a protein named MIR7-3, which has been shown to cause inflammation and contribute to the development of these disorders.
The MIR7-3HG gene has been shown to be highly expressed in the brain and has been implicated in the development and progression of neurodegenerative diseases. Studies have also shown that MIR7-3 is involved in the production of reactive oxygen species (ROS), which can cause oxidative stress and contribute to the development of neurodegeneration.
In addition to its potential role in the development of neurodegenerative diseases, MIR7-3HG has also been shown to be involved in the regulation of inflammation. Studies have shown that MIR7-3 can inhibit the production of pro-inflammatory cytokines and modulate the activity of immune cells, which may have implications for the treatment of autoimmune disorders.
The MIR7-3HG gene has also been implicated in the development of psychiatric disorders. Studies have shown that MIR7-3 is involved in the regulation of dopamine release and that its expression is associated with the development of ADHD and other psychiatric disorders.
In conclusion, the MIR7-3HG gene has emerged as a promising drug target and biomarker for various neurological and psychiatric disorders. Further research is needed to understand the precise role of MIR7-3HG in the development and progression of these conditions and to explore its potential as a therapeutic approach.
Protein Name: MIR7-3 Host Gene
More Common Targets
MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B
